x

Search for a networks

* (*) mandatory field

An Extension Trial Evaluating the Long-term Safety and Efficacy of Dasiglucagon for the Treatment of Children With Congenital Hyperinsulinism

  • Type of network : Multinational clinical trials
  • Geographic coverage : Global
  • Funding body(ies) : ZEALAND PHARMA A/S 
  • Sponsor : Information not provided
  • Website
  • Coordinator of multinational clinical trial

  • INFORMATION NOT PROVIDED
  • Zealand Pharma A/S
  • Smedeland 36
  • 2600 GLOSTRUP
  • DENMARK
  • More information
  • Phone  : 0045 88 77 36 00
  • Fax  : -
  • Website
  • Contact secretary  :
Last update: July 2019

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.